Eradikate Clarifying Acne

Description

UC EradiKate Clarifying Acne Gel Cleanser is a topical formulation designed for the management of acne. This product is presented in a 4-ounce container. The gel cleanser is specifically formulated to help clarify the skin and reduce the appearance of acne. Its composition includes active ingredients that target acne-causing factors while maintaining skin integrity. The product is intended for external use and should be applied as directed for optimal results.

Uses and Indications

This drug is indicated for the treatment of acne. It helps keep the skin clear of new acne blemishes.

Dosage and Administration

The recommended dosage for application is a quarter-sized amount, to be dispensed and gently massaged onto a wet face, avoiding the eye area. This should be performed twice daily, in the morning and evening. After application, the product must be rinsed thoroughly and the face patted dry.

In cases where bothersome dryness or peeling occurs, it is advised to reduce the frequency of application to once daily or every other day, as needed.

Contraindications

Use of this product is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance should be sought or a poison control center contacted.

Warnings and Precautions

FOR EXTERNAL USE ONLY. This product is intended solely for topical application.

Skin irritation or dryness may be exacerbated if used concurrently with other topical acne medications. It is recommended that only one topical acne treatment be utilized at a time to minimize the risk of irritation. Should any signs of irritation occur, the use of the product should be discontinued immediately.

In the event of a rash, it is imperative to stop using the product and consult a healthcare professional for further evaluation and guidance.

Emergency medical assistance should be sought if the product is ingested. In such cases, contacting a poison control center or seeking immediate medical help is essential.

Healthcare professionals are advised to monitor patients for any adverse reactions, particularly skin-related issues, and to provide appropriate recommendations based on individual patient needs.

Side Effects

Patients using this product should be aware that it is intended for external use only. During treatment, skin irritation or dryness may occur, particularly if another topical acne medication is used concurrently. In such cases, it is advised to limit the use to one topical acne medication at a time to minimize the risk of irritation.

In the event that a rash develops, patients are instructed to discontinue use and consult a healthcare professional for further guidance.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation or dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Eradikate Clarifying Acne (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event that the product is swallowed, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Safety during pregnancy has not been established for the use of this product. The use of salicylic acid during pregnancy is generally contraindicated due to potential risks to the fetus, which may include teratogenic effects. Pregnant individuals are advised to consult a healthcare provider before using this product, as there may be risks associated with its use. It is recommended to avoid the use of this product during pregnancy unless specifically directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should be instructed to seek medical help immediately or contact a poison control center for assistance. It is essential for patients to understand the importance of these precautions to ensure their safety and the safety of others.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and protected from light exposure. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with a recommended application of a quarter-sized amount to be gently massaged onto a wet face in the morning and evening, while avoiding the eye area. After application, it should be rinsed thoroughly and patted dry.

Clinicians should advise patients that if bothersome dryness or peeling occurs, they may reduce the frequency of application to once a day or every other day. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Eradikate Clarifying Acne, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)